Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Corpechot

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2023
Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits"Yasmina Chouik, Christophe Corpechot, Claire Francoz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 28, 2022
Liver transplantation for autoimmune hepatitis: Pre-transplant does not predict the early post-transplant outcomeYasmina Chouik, Claire Francoz, Eleonora De Martin, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
The American Journal of Gastroenterology|January 9, 2023
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary CholangitisRozanne C de Veer, Maria C van Hooff, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural historyCarla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 3, 2023
Autoimmune hepatitis recurrence after liver transplantation: "Les jeux sont faits"Yasmina Chouik, Christophe Corpechot, Claire Francoz, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 28, 2022
Liver transplantation for autoimmune hepatitis: Pre-transplant does not predict the early post-transplant outcomeYasmina Chouik, Claire Francoz, Eleonora De Martin, et al.
Alimentary Pharmacology & Therapeutics|October 18, 2019
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment responseCarla F Murillo Perez, Gideon M Hirschfield, Christophe Corpechot, et al.
The American Journal of Gastroenterology|January 9, 2023
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary CholangitisRozanne C de Veer, Maria C van Hooff, Christophe Corpechot, et al.
Hepatology (Baltimore, Md.)|December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural historyCarla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.
European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2022
Liver transplant-free survival according to alkaline phosphatase and GLOBE score in patients with primary biliary cholangitis treated with ursodeoxycholic acidRozanne C de Veer, Maren H Harms, Christophe Corpechot, et al.
Gastroenterology|August 28, 2014
Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up studyWillem J Lammers, Henk R van Buuren, Gideon M Hirschfield, et al.
The New England Journal of Medicine|November 14, 2023
Efficacy and Safety of Elafibranor in Primary Biliary CholangitisKris V Kowdley, Christopher L Bowlus, Cynthia Levy, et al.
European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.
Pageof 12